Development and evaluation of copper-containing mesoporous bioactive glasses for bone defects therapy

J Jimenez-Holguin,S Sanchez-Salcedo,M Vallet-Regi,A J Salinas

DOI: https://doi.org/10.48550/arXiv.2103.11461

2021-03-21

Quantitative Methods

Abstract:Mesoporous bioactive glasses, MBG, are gaining increasing interest in the design of new biomaterials for bone defects treatment. An important research trend to enhance their biological behavior is the inclusion of moderate amounts of oxides with therapeutical action such as CuO. In this paper, MBG with composition were synthesized, investigating the influence of the CuO content and some synthesis parameters in their properties. Two batch were developed; first one using HCl as catalyst and chlorides as CaO and CuO precursors, second one, using HNO3 and nitrates. MBG of chlorides batch exhibited calcium/copper phosphate nanoparticles, between 10 and 20 nm. Nevertheless, CuO- containing MBG of nitrates batch showed nuclei of metallic copper nanoparticles larger than 50 nm and quicker in vitro bioactive responses. Thus, they were coated by an apatite-like layer after 24 h soaked in simulated body fluid, a remarkably short period for MBG containing up to 5 % of CuO. A model, focused in the copper location in the glass network, was proposed to relate nanostructure and in vitro behaviour. Moreover, after 24 h in MEM or THB culture media, all the MBG released therapeutic amounts of Ca2+ and Cu2+ ions. Because the quick bioactive response in SBF, the capacity to host biomolecules in their pores and to release therapeutic concentrations of Ca2+ and Cu2+ ions, MBG of the nitrate batch are considered as excellent biomaterials for bone regeneration.